Chromosome 6p Amplification in Aqueous Humor Cell-Free DNA Is a Prognostic Biomarker for Retinoblastoma Ocular Survival.


Journal

Molecular cancer research : MCR
ISSN: 1557-3125
Titre abrégé: Mol Cancer Res
Pays: United States
ID NLM: 101150042

Informations de publication

Date de publication:
08 2020
Historique:
received: 09 01 2020
revised: 10 04 2020
accepted: 18 05 2020
pubmed: 22 5 2020
medline: 3 7 2021
entrez: 22 5 2020
Statut: ppublish

Résumé

Aqueous humor contains tumor-derived cell-free DNA (cfDNA) and can serve as a liquid biopsy for retinoblastoma. We previously associated somatic copy-number alteration (SCNA) 6p gain with a 10-fold increased risk of enucleation. Here we provide a 2-year update to further explore 6p gain as a prognostic biomarker for ocular survival. Patients diagnosed with retinoblastoma from December 2014 to July 2019 from whom aqueous humor was sampled were included. cfDNA was extracted and shallow whole-genome sequencing performed to identify highly recurrent retinoblastoma SCNAs (gain of 1q, 2p, 6p, loss of 13q, 16q). 116 aqueous humor samples from 50 eyes of 46 patients were included: 27 eyes were salvaged, 23 were enucleated. Highly recurrent retinoblastoma SCNAs were found in 66% eyes. 6p gain was the most prevalent SCNA (50% eyes). It was particularly more prevalent in enucleated eyes (73.9%) than in salvaged eyes (29.6%;

Identifiants

pubmed: 32434859
pii: 1541-7786.MCR-19-1262
doi: 10.1158/1541-7786.MCR-19-1262
pmc: PMC7415535
mid: NIHMS1597947
doi:

Substances chimiques

Biomarkers, Tumor 0
Cell-Free Nucleic Acids 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1166-1175

Subventions

Organisme : NCI NIH HHS
ID : K08 CA232344
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA014089
Pays : United States
Organisme : NEI NIH HHS
ID : P30 EY029220
Pays : United States

Informations de copyright

©2020 American Association for Cancer Research.

Références

Biochim Biophys Acta. 2016 Dec;1866(2):300-319
pubmed: 27742530
Sci Rep. 2016 Apr 29;6:25264
pubmed: 27126562
Ophthalmic Genet. 2014 Dec;35(4):193-207
pubmed: 25321846
J Pediatr Ophthalmol Strabismus. 2018 May 1;55(3):182-188
pubmed: 29257183
Cancer Res. 1999 Nov 15;59(22):5687-91
pubmed: 10582685
Recent Results Cancer Res. 2003;161:73-80
pubmed: 12528800
J Clin Oncol. 2019 Nov 1;37(31):2883-2891
pubmed: 31539297
Saudi J Ophthalmol. 2013 Jul;27(3):147-50
pubmed: 24227979
Neoplasia. 2005 Jun;7(6):603-13
pubmed: 16036111
Pediatr Blood Cancer. 2006 Nov;47(6):801-5
pubmed: 16358310
Clin Transl Med. 2017 Nov 9;6(1):42
pubmed: 29124525
Genes Chromosomes Cancer. 2007 Feb;46(2):118-29
pubmed: 17099872
Br J Ophthalmol. 2019 Feb 11;:
pubmed: 30745306
Retina. 2002 Dec;22(6):707-10
pubmed: 12476095
Genes Chromosomes Cancer. 1999 Apr;24(4):306-14
pubmed: 10092128
Ophthalmology. 2017 Apr;124(4):488-495
pubmed: 28089679
Genes Chromosomes Cancer. 2007 Jul;46(7):617-34
pubmed: 17437278
Lancet Oncol. 2013 Apr;14(4):327-34
pubmed: 23498719
J Clin Pathol. 2007 Jan;60(1):1-7
pubmed: 16790693
Mol Cancer Res. 2018 Nov;16(11):1701-1712
pubmed: 30061186
Nat Protoc. 2016 Mar;11(3):616
pubmed: 26914320
Pediatr Blood Cancer. 2017 Dec;64(12):
pubmed: 28646513
Acta Ophthalmol. 2009 Sep;87(6):588-601
pubmed: 19719804
Pediatr Blood Cancer. 2013 Apr;60(4):688-93
pubmed: 22997170
PLoS One. 2016 Apr 26;11(4):e0153323
pubmed: 27115612
JAMA Ophthalmol. 2017 Nov 1;135(11):1221-1230
pubmed: 29049475
Proc Natl Acad Sci U S A. 2018 Feb 6;115(6):E1229-E1238
pubmed: 29374092
Br J Ophthalmol. 2012 Aug;96(8):1084-7
pubmed: 22368262
Cancer. 1984 Jul 1;54(1):73-8
pubmed: 6722746
Ophthalmology. 1985 Dec;92(12):1763-7
pubmed: 4088631
Ophthalmol Clin North Am. 2005 Mar;18(1):41-53, viii
pubmed: 15763190
Mod Pathol. 2004 Apr;17(4):449-55
pubmed: 14976537
Pediatr Blood Cancer. 2018 Oct;65(10):e27257
pubmed: 29797634
Oncogene. 2005 Sep 22;24(42):6441-9
pubmed: 16007192
Br J Cancer. 2005 Aug 22;93(4):387-91
pubmed: 16106245
Monogr Clin Cytol. 2012;21:72-81
pubmed: 22024586
Ophthalmology. 2015 May;122(5):1016-22
pubmed: 25616769
Nat Protoc. 2012 May 03;7(6):1024-41
pubmed: 22555242
Cancer Genet Cytogenet. 2001 Aug;129(1):57-63
pubmed: 11520568
Clin Exp Ophthalmol. 2014 Jan-Feb;42(1):33-52
pubmed: 24433356
Ophthalmology. 2017 Dec;124(12):1817-1825
pubmed: 28655537
Acta Ophthalmol Scand. 1999 Aug;77(4):448-52
pubmed: 10463420
Ophthalmology. 2017 Oct;124(10):1548-1555
pubmed: 28545735
Cancer Genet Cytogenet. 2003 Oct 1;146(1):8-15
pubmed: 14499690
Neoplasia. 2018 Aug;20(8):757-763
pubmed: 29940303
Ophthalmology. 1993 Nov;100(11):1677-84
pubmed: 8233394
Cancer Med. 2017 Mar;6(3):619-630
pubmed: 28211617

Auteurs

Liya Xu (L)

The Vision Center at Children's Hospital Los Angeles, Los Angeles, California.
Department of Biological Sciences, Dornsife College of Letters, Arts, and Sciences, University of Southern California, Los Angeles, California.
The Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California.

Ashley Polski (A)

The Vision Center at Children's Hospital Los Angeles, Los Angeles, California.
USC Roski Eye Institute, Keck Medical School of the University of Southern California, Los Angeles, California.

Rishvanth K Prabakar (RK)

Department of Molecular and Computational Biology, University of Southern California, Los Angeles, California.

Mark W Reid (MW)

The Vision Center at Children's Hospital Los Angeles, Los Angeles, California.

Patricia Chevez-Barrios (P)

Departments of Pathology and Genomic Medicine and Ophthalmology, Houston Methodist, Weill Cornell Medical College, Houston, Texas.

Rima Jubran (R)

Department of Hematology-Oncology, Children's Hospital Los Angeles, Los Angeles, California.

Jonathan W Kim (JW)

The Vision Center at Children's Hospital Los Angeles, Los Angeles, California.
USC Roski Eye Institute, Keck Medical School of the University of Southern California, Los Angeles, California.

Peter Kuhn (P)

Department of Biological Sciences, Dornsife College of Letters, Arts, and Sciences, University of Southern California, Los Angeles, California.
The Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California.
Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California.
Department of Aerospace and Mechanical Engineering, Viterbi School of Engineering, University of Southern California, Los Angeles, California.
Department of Biomedical Engineering, Viterbi School of Engineering, University of Southern California, Los Angeles, California.

David Cobrinik (D)

The Vision Center at Children's Hospital Los Angeles, Los Angeles, California.
The Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California.
USC Roski Eye Institute, Keck Medical School of the University of Southern California, Los Angeles, California.
Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California.
Department of Biochemistry and Molecular Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.

James Hicks (J)

Department of Biological Sciences, Dornsife College of Letters, Arts, and Sciences, University of Southern California, Los Angeles, California.
Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California.

Jesse L Berry (JL)

The Vision Center at Children's Hospital Los Angeles, Los Angeles, California. jesse.berry@med.usc.edu.
The Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California.
USC Roski Eye Institute, Keck Medical School of the University of Southern California, Los Angeles, California.
Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH